[ET Net News Agency, 26 May 2022] Simcere Pharmaceutical Group Limited (02096) said
with effect from 25 May 2022, Mr Tang Renhong (Mr Tang), an executive director of the
company, has been appointed as a co-chief executive officer of the company. Mr Tang will
assist Mr Ren Jinsheng, chairman and the chief executive officer of the company, in the
overall leading of the group's research and development affairs and will remain as an
executive director.
Mr Tang has nearly 12 years of experience in pharmaceutical research and development and
management of pharmaceutical companies. (RC)